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Summary
Background: Optimization of coronary angioplasty in bifurcation lesions remains a major challenge for per-
cutaneous revascularization techniques.
Material/Methods: We evaluated procedural success, major in-hospital complications, target vessel revasculariza-
tion, and 2-year clinical outcomes in 45 patients who underwent PTCA of a bifurcation lesion
using currently available techniques and rigorous criteria for optimal immediate result.
Results: Angiographic success occurred in 100% of the parent vessels and in 84.4% of both vessels.
Within the first 24 hours, there were no deaths or Q-wave myocardial infarction. Three non-
Q-wave myocardial infarctions occurred (6.6%) and one emergency PTCA was necessary
(2.2%). Therefore, clinical success was achieved in 91.2% of these patients. At 2-year follow-up,
3 cardiac deaths had occurred, the target revascularization rate was 20%, and the total fre-
quency of major adverse cardiac events (MACE) was 37.8%.
Conclusions: Optimization of coronary angioplasty in bifurcation lesions is possible and results in a high
angiographic success rate, low risk of acute complications and acceptable long-term clinical
outcomes. However, the fairly high incidence of MACE at 2 years suggests that bifurcation
lesions remain a challenge in everyday practice despite contemporary intervention methods
and the use of GPIIb/IIIa inhibitors.
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BACKGROUND
Optimization of coronary angioplasty in bifurcation
lesions remains one of the unresolved problems in per-
cutaneous revascularization [1]. Advances in coronary
stenting have dramatically reduced the periprocedural
complications of coronary angioplasty. The possibilities
for safe treatment of patients with complex lesions and
multivessel disease, who would previously have been
considered candidates for surgical treatment only [2],
have markedly expanded. On the average, the acute
and long-term outcomes of percutaneous interventions
have consistently improved with the widespread use of
stents [3]. On the other hand, the cost of stent is still a
concern, preventing more widespread use, particularly
in countries where public funding limitations are an
important factor in health care strategies.
Apart from the economic aspect, the nearly universal
utilization of coronary stents has not eliminated all the
complications involved in percutaneous revasculariza-
tion. In-stent restenosis has emerged as a new clinical
entity [4], and the occurrence of side branch compro-
mise has not decreased with stent placement in compar-
ison to balloon angioplasty [5]. Despite significant
progress in technology, these two factors have stalled
any major breakthrough in the treatment of bifurcation
lesions [6].
Several stenting techniques have been proposed for the
treatment of bifurcation stenoses: ‘T-stenting’ [7], ‘V-
stenting’ [8], ‘Y-stenting’ [9], ‘trouser-leg stenting’ [10],
and the ‘culotte’ technique [11]. More recently, it has
been shown that those approaches which are based on
stenting both the parent vessel and the side branch pro-
vide no advantage over stenting one vessel and per-
forming balloon angioplasty alone in the other [12,13].
The purpose of the present study was to examine short-
and long-term outcomes in an unselected cohort of
patients treated for bifurcation coronary stenoses with
currently available techniques and rigorous criteria for
optimal immediate results.
MATERIAL AND METHODS
Forty-five patients who presented with symptomatic
coronary bifurcation lesions and underwent angioplasty
and/or stenting between January 1998 and June 1999
were included in our study. A minimum side branch
diameter of 2 mm by visual estimate was a prerequisite
for inclusion. Informed consent for coronary angiogra-
phy and percutaneous intervention was obtained from
all patients. Based on the angiographic picture, the
lesions were qualified as types 1-4b as previously
described [14] (Figure 1).
The baseline demographic and clinical data are present-
ed in Table 1. Type 1 bifurcation lesions (‘true’ bifurca-
tion lesions, with more than 50% stenosis of both the
parent vessel and the ostium of the side branch) were
found in 19 patients. Lesion types 2-4b were diagnosed
in 26 patients.
All patients were treated with aspirin and ticlopidine at
the moment of intervention. The transfemoral
approach was used throughout and heparin was admin-
istered prior to the procedure (100 U/kg followed by
additional doses to maintain the ACT above 300 s). Dual
guide wiring was mandatory in Type 1 bifurcation
lesions, while in other lesion types it was used at the
operator’s discretion. ‘Kissing’ balloons were also used
at the operator’s discretion, guided by the angiographic
result. Stents were implanted in the parent vessel in the
event of a suboptimal angiographic result of angioplasty
(>30% residual diameter stenosis) or for abrupt or
Mean age 56±8 years
Male sex 36 (80%)
Hypertension 19 (42%)
Diabetes 4 (9%)
Hyperlipidemia 22 (49%)
Smoking 34 (76%)
Family history 28 (62%)
LAD/Dg 56%
RCA/RPD 2%
CX/OM 40%
LMCA/LAD/IM 2%
Stable angina 32 (71%)
Unstable angina 13 (29%)
Previous MI 21 (47%)
Previous PTCA 0 (0%)
Previous CABG 0 (0%)
MI – myocardial infarction; PTCA – percutaneous transluminal coronary
angioplasty; CABG – coronary artery bypass grafting;
LAD – left anterior descending coronary artery; Dg – diagonal branch;
CX – circumflex coronary artery; OM – obtuse marginal branch;
RCA – right coronary artery, RPD – right posterior descending coronary artery;
LMCA – left main coronary artery; IM – intermediate branch (ramus)
Demography and risk factors 
Distribution of the lesions in the coronary tree
Clinical presentation
Table 1. Baseline demographic and clinical characteristics of the study
group.
Figure 1. Classification of bifurcation lesions according to the distribu-
tion of the plaque material in the parent and branch vessels.
Type 1, the ‘true bifurcation lesion’ is characterized by the
presence of narrowing in the parent vessel both beyond and
beneath the side branch, as well as by the disease of the
side branch. In contrast, in types 2-4b, some portion of the
parent vessel or the side branch is free of significant steno-
sis, but the localization of the plaques puts the side branch at
risk.
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threatened vessel closure. Stenting of the side branch
along with the parent vessel was permitted only in the
event of an abrupt or threatened vessel closure.
Indications for the use of abciximab (bolus 0.25 mg/kg
i.v. + infusion of 0.125 µg/kg/min. i.v. over 12 hours)
included abrupt or threatened vessel closure with visible
thrombus, suboptimal result after stenting (more than
30% residual stenosis), and the presence of slow flow
post procedure – Thrombolysis in Myocardial Infarction
(TIMI) grade 2 [15] – or the ‘no reflow’ phenomenon.
On-line and post-hoc quantitative coronary angiogra-
phy (QCA) was perfomed with an ACA DCI system inte-
grated into Philips Integris HM3000 angiographic
equipment. The reference lumen diameter and mini-
mum lumen diameter (MLD) were measured before
and after percutaneous transluminal coronary angio-
plasty (PTCA). In the parent vessel, the diameter proxi-
mal to the stenosis was used as the reference diameter.
In the side branch, the diameter distal to the stenosis
was used as the reference diameter. Angiographic suc-
cess was defined as residual stenosis of less than 30% of
the reference diameter in the presence of TIMI 3 flow,
and was determined separately for the parent vessel and
the side branch. Procedural success was defined as
angiographic success in the absence of major adverse
cardiac events (MACE), resulting in the relief of angina
or reduction of ischemia in a stress test. The events con-
sidered as MACE were death, myocardial infarction, or
target lesion revascularization (TLR) by means of PTCA
or coronary artery bypass grafting (CABG). Electro-
cardiograms and creatine kinase isoform MB levels were
obtained every 6 hours during the first 24 hours post-
procedure, and every 24 hours afterwards, until dis-
charge. A diagnosis of Q wave myocardial infarction
(QWMI) was made in the presence of new pathological
(>0.04 s) Q waves in the electrocardiogram accompa-
nied by an elevation of creatine kinase isoform MB by
more than 3 times the normal value. A diagnosis of non-
Q wave myocardial infarction (NQWMI) was made in
presence of an elevation of creatine kinase isoform MB by
more than 3 times the normal value without new patho-
logical Q waves in the electrocardiogram. Emergency
revascularization was defined as CABG or repeat PTCA
within the first 24 hours after the procedure.
Clinical follow-up was performed by means of patient
interview and documentation review for the occurrence
of MACE at 24 hours, 30 days, 7 months and 2 years
after the procedure. TLR was defined as any CABG or
repeat PTCA to either the parent vessel or side branch,
or both. An exercise treadmill test was performed after
1, 3 and 6 months. Patients who had angina and/or
recurrence of ischemia in exercise electrocardiogram
were subjected to repeat coronary angiogram.
Statistical analysis 
Continuous variables are expressed as means ± stan-
dard deviation and were compared by means of the t-
test. Frequencies are expressed as percentages and were
compared by means of the chi-squared test. P<0.05 was
considered significant.
RESULTS
Two guidewires were used in 76% of the cases (95% in
type 1 lesions, 54% in types 2-4b). ‘Kissing’ balloon infla-
tions were performed in 24% of the cases (37% in type 1
lesions, 15% in types 2-4b). Stents were implanted in 24
bifurcations (53%): in 20 parent vessels, in 3 side
branches and in both vessels in 1 patient. The stent
types utilized were Crossflex (Cordis, n=9), Palmaz-
Schatz (Cordis, n=7), Multilink Duet (Guidant, n=3),
Crown (Cordis, n=3), Jostent (Jomed, n=2), NIR Primo
(Boston Scientific, n=1).
Angiographic success occurred in 100% of the parent
vessels (n=45) and in both vessels in 84.4% of the pa-
tients (n=38). The reasons for failure in the side branch
were suboptimal dilatation (more than 30% residual ste-
nosis, n=5, 11.1%) or side branch closure (n=2, 4.5%)
On the average, angioplasty resulted in a significant
increase in MLD and a significant reduction in the per-
centage of stenosis in both parent vessels and side
branches. QCA results are shown in Figure 2.
There were no deaths or QWMIs within the first 24
hours. Three patients suffered from NQWMI (6.6%),
and one emergency PTCA was necessary (2.2%).
Therefore, the overall incidence of MACE at 24 hours
was 8.8%. Accordingly, clinical success was achieved in
91.2% of these patients.
 MLD
0
1
2
3
Parent vessel Side branch
mm
Baseline
Post PTCA
Baseline
Post PTCA
%DS
0
20
40
60
80
Parent vessel Side branch
%
68.2±12.2
0.98±0.42
2.37±0.50
0.75±0.20
1.73±0.40
22.8±6.3
69.1±10.2
33.3±5.2
p < 0.001p < 0.001
p < 0.001 p < 0.001
Figure 2. Improvement in lumen size of the parent vessel and the side
branch from baseline (solid bars) to post-intervention (open
bars) measured by quantitative coronary angiography (QCA).
Upper panel: MLD – minimal luminal diameter (mm); lower
panel: %DS – percent diameter stenosis (%).
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After 30 days, there had been no other MACEs with the
exception of one additional TLR. Thus the overall inci-
dence of MACE at 30 days follow-up was 11.1%.
At 7 months of follow-up, two cardiac deaths had
occurred. No autopsy was performed, but it is very like-
ly that these deaths resulted from occlusions in lesions
previously subjected to angioplasty. In both cases, after
stenting of the parent vessels, re-dilation of side branch-
es through the stent struts was performed without ‘kiss-
ing’ balloon inflations. No further myocardial infarc-
tions were observed. Six additional patients had
ischemia requiring repeat angiograms, which in all cases
resulted in PTCA of the target lesion. Therefore, the
TLR rate after 7 months reached 17.8%, while the total
frequency of MACE was 28.9%. Accordingly, 71.1%
patients remained free from MACE and free from angi-
na at 7-month follow-up.
Between 7 months and 2 years, 1 more death occurred,
1 QWMI and 1 NQWMI were recorded, and 1 addi-
tional TLR was necessary. Thus the TLR rate at 2 years
was 20%, and the total incidence of MACE was 37.8%.
The results achieved in the group of patients presenting
initially with the so-called ‘true bifurcation lesion’, i.e.
type 1, were initially similar to the results in patients
with the other types of bifurcation lesions, i.e. types 2-
4b. In fact, in the group with type 1 lesions, no MACEs
were observed after 24 hours. All NQWMI occurred in
the first 24 hours in patients with lesion types 2-4b, and
there was 1 cardiac death in each of these two sub-
groups at 7 months follow-up (Table 2). However,
between 7 months and 2 years relatively more events
occurred in patients with type 1 lesions than in those
with lesion types 2-4b.
DISCUSSION
The treatment of coronary bifurcation stenoses contin-
ues to be a major challenge for percutaneous revascu-
larization techniques. Early reports of balloon angio-
plasty identified shifting of the plaque material from the
parent vessel to the side branch as a mechanism leading
to stenosis or occlusion of the side branch [16,17]. To
adequately protect the side branches, double wiring
[18,19] and the kissing balloon technique [20] were
introduced. However, reports from balloon angioplasty
for bifurcation stenoses have continued to show high
rates of procedural complications, as well as unfavorable
long-term outcomes [21].
The technique of implanting a stent across an ostium
of a lateral branch continued to cause the ‘snow-plow’
effect as much as did balloon angioplasty [5]. Over the
last few years, immediate and long-term clinical out-
comes of bifurcation stenting have improved substan-
tially [7,11,14]. Most recently, two studies from expe-
rienced institutions involving a total of more than 200
patients found that stenting of both branches provides
no advantage over stent placement in the parent ves-
sel with balloon angioplasty of the other branch
[12,13].
The present study reports on an unselected series of
patients, in whom the majority of recently proposed
modifications have been utilized in approaching bifurca-
tion stenoses. In all but one case, stenting was per-
formed in only one of the two vessels. Angiographic suc-
cess was defined as less than 30% residual stenosis, a cri-
terion equally or more rigorous than those applied in
some recent studies [12,13]. This strategy yielded good
procedural outcomes, as well as intermediate-term (7-
month) results comparable with recent studies [14], with
a 17.8% target revascularization rate and 28.9% inci-
dence of total MACE. However, between 7 months and
2 years the adverse events continued to accumulate and
amounted up to 37.8%.
Obviously, numerous patients with bifurcation stenoses
suffer from severe coronary disease, which means that
many of the MACEs observed over the 2-year follow-up
period may represent progression of this disease. For
this reason, it is likely that this patient population may
particularly benefit from post-intervention pharmaco-
logical adjuncts (e.g. statins) to slow the progression of
atherosclerosis. Nevertheless, additional revasculariza-
tion procedures underscore the high propensity for the
restenosis characteristic of bifurcation disease, regard-
less of the disease progression. The overall target revas-
cularization rate was 17.8% at 7 months and 20% at 2
years. Since there was no angiographic follow-up, the
binary angiographic restenosis rate is unknown. It is
well known, however, that many cases of bifurcation
restenosis remain asymptomatic, and that the TLR rates
are thus much lower than the binary restenosis rates [7].
In summary, despite technological and pharmacological
advances, bifurcation lesions still present several factors
for increased risk of MACE in the long run. In diabetic
patients, a bifurcation lesion is an independent predic-
Cardiac death
QMI
NQWMI
CABG
TLR
Total MACE
Cardiac death
QMI
NQWMI
CABG
TLR
Total MACE
0
0
0
0
0
0
0
0
3 (11.5%)
0
1 (3.8%)
4 (15.4%)
0
0
0
0
1 (5.3%)
1 (5.3%)
0
0
3 (11.5%)
0
1 (3.8%)
4 (15.4%)
1 (5.3%)
0
0
0
3 (15.8%)
4 (21.1%)
1 (3.8%)
0
3 (11.5%)
0
5 (19.2%)
9 (34.6%)
1 (5.3%)
1 (5.3%)
1 (5.3%)
0
4 (21.1%)
7 (36.8%)
2 (7.7%)
0
3 (11.5%)
0
5 (19.2%)
10 (38.5%)
QWMI – Q wave myocardial infarction; NQWMI – non-Q wave myocardial
infarction; CABG – coronary artery bypass grafting; TLR – target lesion
revascularization, MACE – major adverse cardiac events
Lesion type 1
(n=19)
Lesion type 2–4b
(n=26)
24 hours
24 hours
30 days
30 days
7 months
7 months
2 years
2 years
Table 2. Incidence of major adverse cardiac events in subgroups
according to the lesion type: type 1 lesion ("true bifurcation
lesions", n=19) vs. lesion types 2–4b (n=26). Percentages
are relative to the numbers of patients in each subgroup.
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tor of restenosis [22]. Stent overlap, often occurring in
the treatment of bifurcation lesions, has been associated
with increased risk of MACE after 30 days [23].
Interventions in bifurcation stenoses create the potential
for increased risk of restenosis by utilizing multiple
stents [24,25]. Branch salvage has also been demonstrat-
ed to result in increased restenosis [19]. The prelimi-
nary data indicate that drug-eluting stents may reduce
the incidence of restenosis, but their impact on the
treatment of bifurcation lesions is virtually unknown at
present. While technical advances have made it possible
to tackle increasingly anatomically complex coronary
problems, restenosis is the limiting factor for long-term
success in bifurcation angioplasty. For this reason, it
should be emphasized that CABG, with its current low
complication rate, the increasing frequency of off-pump
bypass and excellent long-term freedom from angina,
remains a viable option for multivessel disease, includ-
ing bifurcation stenoses not easily amenable to angio-
plasty and stenting [2].
CONCLUSIONS
The present study, along with those of other authors,
emphasizes the continuous need to adhere to evidence-
based recommendations (avoiding multiple stents and
stenting of the side branch, attempting kissing balloon
inflations as often as technically possible). Refinement of
success criteria for immediate results is necessary in
order to optimize the long-term outcomes in patients
treated for coronary bifurcation stenoses. In addition,
since many of these patients have advanced atheroscle-
rosis, it is likely that they may particularly benefit from
post-intervention pharmacological adjuncts (e.g. statins)
to slow the progression of atherosclerosis.
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